↓ Skip to main content

Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate Asthma

Overview of attention for article published in Annals of Allergy, Asthma & Immunology, April 1997
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy
1 policy source
patent
3 patents

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate Asthma
Published in
Annals of Allergy, Asthma & Immunology, April 1997
DOI 10.1016/s1081-1206(10)63196-1
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 3 11%
Student > Bachelor 3 11%
Student > Master 3 11%
Researcher 3 11%
Lecturer 2 7%
Other 8 30%
Unknown 5 19%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 18 67%
Nursing and Health Professions 2 7%
Biochemistry, Genetics and Molecular Biology 1 4%
Business, Management and Accounting 1 4%
Unknown 5 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2021.
All research outputs
#3,731,343
of 34,089,221 outputs
Outputs from Annals of Allergy, Asthma & Immunology
#931
of 5,077 outputs
Outputs of similar age
#2,874
of 43,404 outputs
Outputs of similar age from Annals of Allergy, Asthma & Immunology
#3
of 22 outputs
Altmetric has tracked 34,089,221 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,077 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 43,404 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.